Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ticagrelor Tablets, 90 mg, and ...

Vadodara: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA) has given final ...

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 90 mg and tentative ...

A multicenter, open-label, randomized controlled trial enrolled 100 patients with BAD-related mild stroke (NIH Stroke Scale score ≤5) across four centers in China. All patients were treated within 48 ...

The primary clinical outcome was the modified Rankin Scale (mRS) score at 90 days, while the secondary outcome was the NIH Stroke Scale (NIHSS) score at 24 hours. This study highlights the prognostic ...